Explore more publications!
Healthy Living South Dakota
Got News to Share?

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 9, 2025

Paragonix Technologies’ KidneyVault® System Safely Transports Donor Kidney from Arizona to Puerto Rico
October 9, 2025

Paragonix Technologies’ KidneyVault® System Safely Transports Donor Kidney from Arizona to Puerto Rico

Indeterminate GlobeNewswire
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology
October 9, 2025

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Indeterminate GlobeNewswire
Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1
October 9, 2025

Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1

Indeterminate GlobeNewswire
Digital Utilities Ventures Completes Acquisition and Name Change
October 9, 2025

Digital Utilities Ventures Completes Acquisition and Name Change

Indeterminate GlobeNewswire
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution
October 9, 2025

Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution

Indeterminate GlobeNewswire
Iolyx Therapeutics Announces Upcoming Presentation at Eyecelerator 2025 and Poster at the American Academy of Ophthalmology Annual Meeting
October 9, 2025

Iolyx Therapeutics Announces Upcoming Presentation at Eyecelerator 2025 and Poster at the American Academy of Ophthalmology Annual Meeting

Indeterminate GlobeNewswire
CytoDyn to Present at the LD Micro Main Event XIX Investor Conference
October 9, 2025

CytoDyn to Present at the LD Micro Main Event XIX Investor Conference

Indeterminate GlobeNewswire
RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
October 9, 2025

RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD

Indeterminate GlobeNewswire
WellBeam to Accelerate Next-Generation Care Coordination with Advocate Health
October 9, 2025

WellBeam to Accelerate Next-Generation Care Coordination with Advocate Health

Indeterminate GlobeNewswire
NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market
October 9, 2025

NKGen Biotech Provides Clarification on Quotation Display and Trading Status on the OTC Expert Market

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
October 9, 2025

Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

Indeterminate GlobeNewswire
NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21
October 9, 2025

NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21

Indeterminate GlobeNewswire
Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025
October 9, 2025

Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025

Indeterminate GlobeNewswire
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
October 9, 2025

vTv Therapeutics Announces New Appointments to its Scientific Advisory Board

Indeterminate GlobeNewswire
ABLi Therapeutics Reports Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease
October 9, 2025

ABLi Therapeutics Reports Final Results from the Phase 2 ‘201 Trial’ Evaluating Risvodetinib for the Treatment of Parkinson’s Disease

Indeterminate GlobeNewswire
Envision Research Institute Publishes Study in PLOS One, Advancing Independence for People With Vision Loss
October 9, 2025

Envision Research Institute Publishes Study in PLOS One, Advancing Independence for People With Vision Loss

Indeterminate GlobeNewswire
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention
October 9, 2025

Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention

Indeterminate GlobeNewswire
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
October 9, 2025

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

Indeterminate GlobeNewswire
Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer
October 9, 2025

Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Cronos launches SOURZ by Spinach® Fully Blasted Multipacks
October 9, 2025

Cronos launches SOURZ by Spinach® Fully Blasted Multipacks

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions